Vascular Adviser Podcast
Por: Vascular Adviser Team
The audio files provided on the Thrombosis Adviser channel are intended for viewers outside the USA and the UK only.
Thrombosis Adviser is an online resource for physicians and patients about current and emerging therapies for thromboembolic disease including venous thrombosis (VTE), atrial fibrillation (AF), and acute coronary syndrome (ACS).
The Thrombosis Adviser podcast series is intended to provide information to HPCs.
Imprint
Published by:
Bayer AG, Leverkusen, Germany
represented by the Management Board:
Werner Baumann, Chairman
Bill Anderson, Sarena Lin, Wolfgang Nickl, Stefan Oelrich, Rodrigo
Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
Tel.: +49 (0)214 30-1
E-mail: Inquiries can be sent to [email protected] or using our contact form.
Entry in the Commercial Register of the Cologne District Court
(Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859
Edited by:
Bayer AG
Communications & Public Affairs
Thrombosis Adviser is an online resource for physicians and patients about current and emerging therapies for thromboembolic disease including venous thrombosis (VTE), atrial fibrillation (AF), and acute coronary syndrome (ACS).
The Thrombosis Adviser podcast series is intended to provide information to HPCs.
Imprint
Published by:
Bayer AG, Leverkusen, Germany
represented by the Management Board:
Werner Baumann, Chairman
Bill Anderson, Sarena Lin, Wolfgang Nickl, Stefan Oelrich, Rodrigo
Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
Tel.: +49 (0)214 30-1
E-mail: Inquiries can be sent to [email protected] or using our contact form.
Entry in the Commercial Register of the Cologne District Court
(Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859
Edited by:
Bayer AG
Communications & Public Affairs
8 episodios disponibles
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.